Steven B. Kanner

City:

Berkeley, California

Country:

United States

Published Applications:

Last publication date:

2025-12-25

Top Assignees for applications by Steven B. Kanner

The entities that hold a legal rights for patent applications filed by inventor Kanner Steven B.:

Arrowhead Pharmaceuticals, Inc. 7 Pasadena, CA United States

Recent patent applications by Kanner Steven B.

Steven B. Kanner from Berkeley, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-12-25

US20250388900A1

Chemistry; metallurgy

Compositions and Methods for Inhibition of Factor XII Gene Expression

#2 | 2025-06-19

US20250197861A1

Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR INHIBITING GENE EXPRESSION OF ALPHA-1 ANTITRYPSIN

#3 | 2023-01-05

US20230002768A1

Chemistry; metallurgy

Compositions and methods for inhibiting gene expression of alpha-1 antitrypsin

#4 | 2021-06-17

US20210180066A1

Chemistry; metallurgy

Compositions and methods for inhibiting gene expression of Hif2alpha

#5 | 2019-12-19

US20190382763A1

Chemistry; metallurgy

Compositions and Methods for Inhibition of Factor XII Gene Expression

#6 | 2019-11-28

US20190359984A1

Chemistry; metallurgy

Compositions and methods for inhibiting gene expression of factor XII

#7 | 2019-09-19

US20190284558A1

Chemistry; metallurgy

Compositions and methods for inhibiting gene expression of alpha-1 AntiTrypsin

#8 | 2018-09-13

US20180258430A1

Chemistry; metallurgy

Compositions and Methods for Inhibiting Gene Expression of Alpha-1 AntiTrypsin

#9 | 2018-08-16

US20180230470A1

Chemistry; metallurgy

Compositions and methods for inhibiting gene expression of Hif2alpha

#10 | 2018-01-25

US20180023086A1

Chemistry; metallurgy

Compositions and methods for inhibiting gene expression of factor XII

InventorID:

2098426 ⎘